🇺🇸 FDA
Patent

US 10400015

Recombinant HIV-1 envelope proteins and their use

granted A61KA61K2039/55555A61K2039/55561

Quick answer

US patent 10400015 (Recombinant HIV-1 envelope proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K2039/55555, A61K2039/55561, A61K2039/55577, A61K39/12